Figure 3.
Concentration versus time data and model fits of 1,25(OH)2D3 in plasma (circles) and tumor (triangles) after i.p. administration to tumor-bearing nu/nu mice of 20 µg/kg 1,25(OH)2D3 either alone (open symbols, dashed lines) or in combination with 250 µg/kg of the CYP24 inhibitor, CTA091 (solid symbols, solid lines).